In patients with myocardial infarction and preserved left ventricular ejection fraction, withholding or withdrawing beta blockers at discharge was not associated with increased short-term or long-term ischaemic events.
In this episode of Turning Point, we sit down with Dr. Rasha Al-Lamee, a leading interventional cardiologist and researcher whose work has transformed the field.
From her early days as a clinician drawn to evidence-based medicine to leading the groundbreaking ORBITA trial, Dr. Al-Lamee shares the pivotal moments, mentors, and teams that shaped her journey.
Follow our presence throughout the congress and discover our latest scientific contributions. A simultaneous publication will be released on Saturday at 11:00 am CET.